Par, Purdue Settle IP Claims In OxyContin Antitrust MDL
Par Pharmaceutical Cos. Inc. has settled a suit alleging its proposed generic OxyContin infringed Purdue Pharma LP patents for a tamper-resistant form of the widely abused painkiller, according to a consent...To view the full article, register now.
Already a subscriber? Click here to view full article